Survivors at Risk: Hodgkin Lymphoma Survivors at High Risk of Second Cancers
International Journal of Hematologic Oncology · 2017
DOI: 10.2217/ijh-2017-0008 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Hematologic Oncology, 2017. Verfasst von Amit Sud. Beteiligte Einrichtung: Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Amit Sud speaks to Sebastian Dennis-Beron, Commissioning Editor: Amit Sud is a clinical research fellow in Hematology at the Institute of Cancer Research, UK. He undertook his undergraduate medical training at the University of Manchester, gaining an honors degree. He completed his Masters in Medical Research at Manchester University, gaining a distinction. He continued his medical training in Manchester and London and started his specialization in Hematology in South West London. He was successful in obtaining a Cancer Research UK funded clinical research fellowship in Hematology under the supervision of Professor Richard Houlston at the Institute of Cancer Research. His current research focus is that of genetic susceptibility to Hodgkin lymphoma. He is a trainee member of the NCRI Lymphoma Clinical Studies Group.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
Zitieren
APA
Sud, A. (2017). Survivors at Risk: Hodgkin Lymphoma Survivors at High Risk of Second Cancers. International Journal of Hematologic Oncology. https://doi.org/10.2217/ijh-2017-0008
Vancouver
Sud A. Survivors at Risk: Hodgkin Lymphoma Survivors at High Risk of Second Cancers. International Journal of Hematologic Oncology. 2017. doi:10.2217/ijh-2017-0008
BibTeX
@article{Sud2017,
author = {Sud, Amit},
title = {Survivors at Risk: Hodgkin Lymphoma Survivors at High Risk of Second Cancers},
journal = {International Journal of Hematologic Oncology},
year = {2017},
doi = {10.2217/ijh-2017-0008}
}
EUVIMED